Trial intelligence / Profile preview

Different doses of dexmedetomidine for hemodynamic stability and postoperative pain during abdominal surgery

PACTR202208813896934Phase 4Completed

Sponsor
Dilla University
Start
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in postoperative pain (3 arms), sponsored by Dilla University. Primary endpoints: Hemodynamic response to perioperative stimuli and Change from baseline in hemodynamic parameters. Started Aug 2022; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on PACTR202208813896934.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202208813896934.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call